CDP-Choline
•Last Updated: February 8 2023
CDP-Choline is most often used for
Last Updated: February 8 2023
CDP-choline is a nootropic compound that is essentially a prodrug for both choline and uridine, conferring both of those molecules to the body following oral ingestion of CDP-Choline. Specifically, the CDP-choline dissociates into choline and cytidine, with the cytidine then converting into uridine. CDP-choline is one of the three choline-containing phospholipids that can be orally supplemented (the other two being Alpha-GPC and phosphatidylcholine).
This supplement is catered towards preventing or treating memory impairments associated with aging due to the fact that both of the molecules it confers are neuroprotective and potentially enhance learning. While it appears to be more effective than phosphatidylcholine (PC) at this role, in part due to also increasing PC synthesis in the brain, its potency is somewhat comparable to that of Alpha-GPC.
CDP-choline has some other potential uses in relation to cognition. It is commonly used as a memory enhancer in youth, but despite some rodent studies suggesting that this is possible with oral CDP-choline, there are no human studies in youth at this point in time. One study has noted an increase in attention with low dose CDP-choline (which needs to be replicated), and CDP-choline may have roles as an anti-addictive compound against both cocaine and (preliminary evidence suggests) food as well.
Standard dosing of CDP-choline is to take 500-2,000 mg in two divided doses (of 250-1,000 mg) usually separated by 8-12 hours, although a single daily dose is also sometimes used. A single dose of 4,000 mg does not appear to affect the blood any differently than 2,000 mg, and so it is not necessary to take such a high dose.
There are some properties, such as attention-promotion or improving bioenergetics, that seem to respond exclusively or more strongly to the lower dosage range. Other properties like appetite are the opposite, and thus the ideal dosage depends somewhat on the goal.
Research FeedRead all studies
2.^Bracken BK, Penetar DM, Rodolico J, Ryan ET, Lukas SEEight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adultsPharmacol Biochem Behav.(2011 Jun)
3.^Sarkar AK, Ghosh D, Haldar D, Sarkar P, Gupta B, Dastidar SG, Pal TKA rapid LC-ESI-MS/MS method for the quantitation of choline, an active metabolite of citicoline: Application to in vivo pharmacokinetic and bioequivalence study in Indian healthy male volunteersJ Pharm Biomed Anal.(2012 Dec)
4.^Gibellini F, Smith TKThe Kennedy pathway--De novo synthesis of phosphatidylethanolamine and phosphatidylcholineIUBMB Life.(2010 Jun)
6.^Fagone P, Jackowski SPhosphatidylcholine and the CDP-choline cycleBiochim Biophys Acta.(2013 Mar)
7.^Aoyama C, Liao H, Ishidate KStructure and function of choline kinase isoforms in mammalian cellsProg Lipid Res.(2004 May)
9.^Jansen SM, Groener JE, Bax W, Suter A, Saftig P, Somerharju P, Poorthuis BJBiosynthesis of phosphatidylcholine from a phosphocholine precursor pool derived from the late endosomal/lysosomal degradation of sphingomyelinJ Biol Chem.(2001 Jun 1)
10.^Jackowski S, Fagone PCTP: Phosphocholine cytidylyltransferase: paving the way from gene to membraneJ Biol Chem.(2005 Jan 14)
11.^Cornell RB, Northwood ICRegulation of CTP:phosphocholine cytidylyltransferase by amphitropism and relocalizationTrends Biochem Sci.(2000 Sep)
12.^Kent CRegulatory enzymes of phosphatidylcholine biosynthesis: a personal perspectiveBiochim Biophys Acta.(2005 Mar 21)
15.^Henneberry AL, Wistow G, McMaster CRCloning, genomic organization, and characterization of a human cholinephosphotransferaseJ Biol Chem.(2000 Sep 22)
16.^Henneberry AL, McMaster CRCloning and expression of a human choline/ethanolaminephosphotransferase: synthesis of phosphatidylcholine and phosphatidylethanolamineBiochem J.(1999 Apr 15)
17.^Horibata Y, Hirabayashi YIdentification and characterization of human ethanolaminephosphotransferase1J Lipid Res.(2007 Mar)
18.^Wurtman RJ, Regan M, Ulus I, Yu LEffect of oral CDP-choline on plasma choline and uridine levels in humansBiochem Pharmacol.(2000 Oct 1)
19.^Lopez G-Coviella I, Agut J, Von Borstel R, Wurtman RJMetabolism of cytidine (5?)-diphosphocholine (cdp-choline) following oral and intravenous administration to the human and the ratNeurochem Int.(1987)
20.^Galletti P, De Rosa M, Cotticelli MG, Morana A, Vaccaro R, Zappia VBiochemical rationale for the use of CDPcholine in traumatic brain injury: pharmacokinetics of the orally administered drugJ Neurol Sci.(1991 Jul)
21.^Weiss GBMetabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicolineLife Sci.(1995)
22.^Cansev MUridine and cytidine in the brain: their transport and utilizationBrain Res Rev.(2006 Sep)
23.^Vásquez JV, Pinardi GVasomotor responses in the isolated perfused external and internal carotid vascular beds of the ratGen Pharmacol.(1992 Jul)
24.^Edvinsson L, Nielsen KC, Owman C, Sporrong BCholinergic mechanisms in pial vessels. Histochemistry, electron microscopy and pharmacologyZ Zellforsch Mikrosk Anat.(1972)
25.^Iwayama T, Furness JB, Burnstock GDual adrenergic and cholinergic innervation of the cerebral arteries of the rat. An ultrastructural studyCirc Res.(1970 May)
26.^Pinardi G, Pelissier T, Kramer V, Paeile C, Miranda HFEffects of CDP-choline on acetylcholine-induced relaxation of the perfused carotid vascular beds of the ratGen Pharmacol.(1994 Jul)
27.^López-Coviella I, Agut J, Savci V, Ortiz JA, Wurtman RJEvidence that 5'-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levelsJ Neurochem.(1995 Aug)
28.^Cansev M, Yilmaz MS, Ilcol YO, Hamurtekin E, Ulus IHCardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous systemEur J Pharmacol.(2007 Dec 22)
29.^Jochem J, Savci V, Filiz N, Rybus-Kalinowska B, Fogel WA, Yalcin MInvolvement of the histaminergic system in cytidine 5'-diphosphocholine-induced reversal of critical haemorrhagic hypotension in ratsJ Physiol Pharmacol.(2010 Feb)
30.^Savci V, Goktalay G, Cansev M, Cavun S, Yilmaz MS, Ulus IHIntravenously injected CDP-choline increases blood pressure and reverses hypotension in haemorrhagic shock: effect is mediated by central cholinergic activationEur J Pharmacol.(2003 May 9)
31.^Savci V, Cavun S, Goktalay G, Ulus IHCardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic systemNaunyn Schmiedebergs Arch Pharmacol.(2002 May)
32.^Alvarez XA, Laredo M, Corzo D, Fernández-Novoa L, Mouzo R, Perea JE, Daniele D, Cacabelos RCiticoline improves memory performance in elderly subjectsMethods Find Exp Clin Pharmacol.(1997 Apr)
33.^Silveri MM, Dikan J, Ross AJ, Jensen JE, Kamiya T, Kawada Y, Renshaw PF, Yurgelun-Todd DACiticoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopyNMR Biomed.(2008 Nov)
34.^Killgore WD, Ross AJ, Kamiya T, Kawada Y, Renshaw PF, Yurgelun-Todd DACiticoline affects appetite and cortico-limbic responses to images of high-calorie foodsInt J Eat Disord.(2010 Jan)
36.^Rowley TJ, McKinstry A, Greenidge E, Smith W, Flood PAntinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative painBr J Anaesth.(2010 Aug)
37.^Yaksh TL, Dirksen R, Harty GJAntinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and catEur J Pharmacol.(1985 Oct 29)
38.^Gurun MS, Parker R, Eisenach JC, Vincler MThe effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptorAnesth Analg.(2009 May)
39.^Hamurtekin E, Gurun MSThe antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic systemBrain Res.(2006 Oct 30)
40.^Bagdas D, Sonat FA, Hamurtekin E, Sonal S, Gurun MSThe antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain modelsBehav Pharmacol.(2011 Sep)
41.^Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EXCholine is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neuronsEur J Neurosci.(1997 Dec)
42.^Bartolini A, Ghelardini C, Fantetti L, Malcangio M, Malmberg-Aiello P, Giotti ARole of muscarinic receptor subtypes in central antinociceptionBr J Pharmacol.(1992 Jan)
43.^Houdi AA, Pierzchala K, Marson L, Palkovits M, Van Loon GRNicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activityPeptides.(1991 Jan-Feb)
44.^Zarrindast MR, Pazouki M, Nassiri-Rad SInvolvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociceptionPharmacol Toxicol.(1997 Nov)
45.^Zarrindast MR, Nami AB, Farzin DNicotine potentiates morphine antinociception: a possible cholinergic mechanismEur Neuropsychopharmacol.(1996 May)
46.^Hamurtekin E, Bagdas D, Gurun MSPossible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in ratsNeurosci Lett.(2007 Jun 13)
47.^Adibhatla RM, Hatcher JF, Dempsey RJCiticoline: neuroprotective mechanisms in cerebral ischemiaJ Neurochem.(2002 Jan)
48.^Plataras C, Tsakiris S, Angelogianni PEffect of CDP-choline on brain acetylcholinesterase and Na(+), K(+)-ATPase in adult ratsClin Biochem.(2000 Jul)
49.^Rao AM, Hatcher JF, Dempsey RJLipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotectionJ Neurochem.(2000 Dec)
50.^Dorman RV, Dabrowiecki Z, Horrocks LAEffects of CDPcholine and CDPethanolamine on the alterations in rat brain lipid metabolism induced by global ischemiaJ Neurochem.(1983 Jan)
51.^Adibhatla RM, Hatcher JF, Dempsey RJEffects of citicoline on phospholipid and glutathione levels in transient cerebral ischemiaStroke.(2001 Oct)
52.^Krupinski J, Ferrer I, Barrachina M, Secades JJ, Mercadal J, Lozano RCDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the ratNeuropharmacology.(2002 May)
53.^Gutiérrez-Fernández M, Rodríguez-Frutos B, Fuentes B, Vallejo-Cremades MT, Alvarez-Grech J, Expósito-Alcaide M, Díez-Tejedor ECDP-choline treatment induces brain plasticity markers expression in experimental animal strokeNeurochem Int.(2012 Feb)
54.^Sahin S, Alkan T, Temel SG, Tureyen K, Tolunay S, Korfali EEffects of citicoline used alone and in combination with mild hypothermia on apoptosis induced by focal cerebral ischemia in ratsJ Clin Neurosci.(2010 Feb)
55.^Andersen M, Overgaard K, Meden P, Boysen G, Choi SCEffects of citicoline combined with thrombolytic therapy in a rat embolic stroke modelStroke.(1999 Jul)
56.^Alonso de Leciñana M, Gutiérrez M, Roda JM, Carceller F, Díez-Tejedor EEffect of combined therapy with thrombolysis and citicoline in a rat model of embolic strokeJ Neurol Sci.(2006 Sep 25)
57.^Schäbitz WR, Weber J, Takano K, Sandage BW, Locke KW, Fisher MThe effects of prolonged treatment with citicoline in temporary experimental focal ischemiaJ Neurol Sci.(1996 Jun)
58.^Schäbitz WR, Li F, Irie K, Sandage BW Jr, Locke KW, Fisher MSynergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemiaStroke.(1999 Feb)
59.^Hurtado O, Hernández-Jiménez M, Zarruk JG, Cuartero MI, Ballesteros I, Camarero G, Moraga A, Pradillo JM, Moro MA, Lizasoain ICiticoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental strokeJ Neurochem.(2013 Apr 18)
60.^Dixon CE, Ma X, Marion DWEffects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine releaseJ Neurotrauma.(1997 Mar)
61.^Zafonte RD, Bagiella E, Ansel BM, Novack TA, Friedewald WT, Hesdorffer DC, Timmons SD, Jallo J, Eisenberg H, Hart T, Ricker JH, Diaz-Arrastia R, Merchant RE, Temkin NR, Melton S, Dikmen SSEffect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)JAMA.(2012 Nov 21)
62.^Dávalos A, Castillo J, Alvarez-Sabín J, Secades JJ, Mercadal J, López S, Cobo E, Warach S, Sherman D, Clark WM, Lozano ROral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trialsStroke.(2002 Dec)
63.^Saver JLCiticoline: update on a promising and widely available agent for neuroprotection and neurorepairRev Neurol Dis.(2008 Fall)
64.^Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, Martínez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ; International Citicoline Trial on acUte Stroke (ICTUS) trial investigatorsCiticoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)Lancet.(2012 Jul 28)
65.^Amenta F, Tayebati SKPathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunctionCurr Med Chem.(2008)
66.^Wang L, Albrecht MA, Wurtman RJDietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged ratBrain Res.(2007 Feb 16)
67.^Tayebati SK, Tomassoni D, Di Stefano A, Sozio P, Cerasa LS, Amenta FEffect of choline-containing phospholipids on brain cholinergic transporters in the ratJ Neurol Sci.(2011 Mar 15)
68.^Tomassoni D, Catalani A, Cinque C, Di Tullio MA, Tayebati SK, Cadoni A, Nwankwo IE, Traini E, Amenta FEffects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive ratsCurr Alzheimer Res.(2012 Jan)
69.^Giménez R, Raïch J, Aguilar JChanges in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging miceBr J Pharmacol.(1991 Nov)
70.^Ilcol YO, Gurun MS, Taga Y, Ulus IHIntraperitoneal administration of choline increases serum glucose in rat: involvement of the sympathoadrenal systemHorm Metab Res.(2002 Jun)
71.^Ilcol YO, Cansev M, Yilmaz MS, Hamurtekin E, Ulus IHIntraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal systemArch Physiol Biochem.(2007 Oct-Dec)
72.^Cansev M, Ilcol YO, Yilmaz MS, Hamurtekin E, Ulus IHPeripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrationsAuton Autacoid Pharmacol.(2008 Jan)
73.^Saligaut C, Daoust M, Moore N, Boismare FEffects of hypoxia and cytidine (5') diphosphocholine on the concentrations of dopamine, norepinephrine and metabolites in rat hypothalamus and striatumArch Int Pharmacodyn Ther.(1987 Jan)
74.^Tayebati SK, Tomassoni D, Nwankwo IE, Di Stefano A, Sozio P, Cerasa LS, Amenta FModulation of monoaminergic transporters by choline-containing phospholipids in rat brainCNS Neurol Disord Drug Targets.(2013 Feb 1)
76.^Wang L, Pooler AM, Albrecht MA, Wurtman RJDietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged ratsJ Mol Neurosci.(2005)
77.^Agut J, Ortiz JA, Wurtman RJCytidine (5')diphosphocholine modulates dopamine K(+)-evoked release in striatum measured by microdialysisAnn N Y Acad Sci.(2000)
78.^Shibuya M, Kageyama N, Taniguchi T, Hidaka H, Fujiwara MEffects of CDP-choline on striatal dopamine level and behavior in ratsJpn J Pharmacol.(1981 Feb)
79.^Dusseau JW, Hutchins PMStimulation of arteriolar number by salbutamol in spontaneously hypertensive ratsAm J Physiol.(1979 Jan)
80.^Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis
81.^Radad K, Gille G, Xiaojing J, Durany N, Rausch WDCDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell cultureInt J Neurosci.(2007 Jul)
82.^Barrachina M, Domínguez I, Ambrosio S, Secades J, Lozano R, Ferrer INeuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cellsJ Neurol Sci.(2003 Nov 15)
83.^Pulvirenti L, Koob GFDopamine receptor agonists, partial agonists and psychostimulant addictionTrends Pharmacol Sci.(1994 Oct)
84.^Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GEFluoxetine alters the effects of intravenous cocaine in humansJ Clin Psychopharmacol.(1994 Dec)
85.^Renshaw PF, Daniels S, Lundahl LH, Rogers V, Lukas SEShort-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary reportPsychopharmacology (Berl).(1999 Feb)
86.^Brown ES, Gorman AR, Hynan LSA randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependenceJ Clin Psychopharmacol.(2007 Oct)
87.^Licata SC, Penetar DM, Ravichandran C, Rodolico J, Palmer C, Berko J, Geaghan T, Looby A, Peters E, Ryan E, Renshaw PF, Lukas SEEffects of daily treatment with citicoline: a double-blind, placebo-controlled study in cocaine-dependent volunteersJ Addict Med.(2011 Mar)
88.^Lukas SE, Kouri EM, Rhee C, Madrid A, Renshaw PFEffects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effectsPsychopharmacology (Berl).(2001 Sep)
89.^Teather LA, Wurtman RJDietary cytidine (5')-diphosphocholine supplementation protects against development of memory deficits in aging ratsProg Neuropsychopharmacol Biol Psychiatry.(2003 Jun)
90.^Petkov VD, Mosharrof AH, Kehayov R, Petkov VV, Konstantinova E, Getova DEffect of CDP-choline on learning and memory processes in rodentsMethods Find Exp Clin Pharmacol.(1992 Oct)
91.^Mosharrof AH, Petkov VDEffects of citicholine and of the combination citicholine + piracetam on the memory (experiments on mice)Acta Physiol Pharmacol Bulg.(1990)
92.^Petkov VD, Mosharrof AH, Petkov VVComparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice)Acta Physiol Pharmacol Bulg.(1988)
93.^Gallagher M, Pelleymounter MASpatial learning deficits in old rats: a model for memory decline in the agedNeurobiol Aging.(1988 Sep-Dec)
94.^Rapp PR, Rosenberg RA, Gallagher MAn evaluation of spatial information processing in aged ratsBehav Neurosci.(1987 Feb)
95.^Albert MNeuropsychological and neurophysiological changes in healthy adult humans across the age rangeNeurobiol Aging.(1993 Nov-Dec)
96.^Rylett RJ, Goddard S, Schmidt BM, Williams LRAcetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 ratsJ Neurosci.(1993 Sep)
97.^Ando S, Tanaka Y, Toyoda nee Ono Y, Kon K, Kawashima STurnover of synaptic membranes: age-related changes and modulation by dietary restrictionJ Neurosci Res.(2002 Nov 1)
98.^Salvador GA, López FM, Giusto NMAge-related changes in central nervous system phosphatidylserine decarboxylase activityJ Neurosci Res.(2002 Nov 1)
99.^Teather LA, Wurtman RJChronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished ratsJ Nutr.(2006 Nov)
100.^Mosharrof AH, Petkov VD, Petkov VVEffects of meclofenoxate and citicholine on learning and memory in aged ratsActa Physiol Pharmacol Bulg.(1987)
101.^Spiers PA, Myers D, Hochanadel GS, Lieberman HR, Wurtman RJCiticoline improves verbal memory in agingArch Neurol.(1996 May)
102.^Takasaki K, Uchida K, Fujikawa R, Nogami A, Nakamura K, Kawasaki C, Yamaguchi K, Morita M, Morishita K, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M, Iwasaki KNeuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementiaJ Pharmacol Sci.(2011)
103.^Ilcol YO, Gurun MS, Taga Y, Ulus IHCholine increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated aceylcholine release from the rat minced pancreas in vitroEur J Biochem.(2003 Mar)
104.^Cansev M, Ilcol YO, Yilmaz MS, Hamurtekin E, Ulus IHCholine, CDP-choline or phosphocholine increases plasma glucagon in rats: involvement of the peripheral autonomic nervous systemEur J Pharmacol.(2008 Jul 28)
105.^Rejdak R, Toczołowski J, Solski J, Duma D, Grieb PCiticoline treatment increases retinal dopamine content in rabbitsOphthalmic Res.(2002 May-Jun)
106.^Parisi V, Manni G, Colacino G, Bucci MGCytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucomaOphthalmology.(1999 Jun)
107.^Parisi V, Coppola G, Centofanti M, Oddone F, Angrisani AM, Ziccardi L, Ricci B, Quaranta L, Manni GEvidence of the neuroprotective role of citicoline in glaucoma patientsProg Brain Res.(2008)
108.^Cavun S, Savci VCDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvementFundam Clin Pharmacol.(2004 Oct)